Company Description
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People’s Republic of China.
The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman’s examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; and medical x-ray films and multi-functional self-extracting X-ray film machines.
The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania.
The company was founded in 1991 and is based in Yangzhou, the People’s Republic of China.
| Country | China |
| Founded | 1990 |
| IPO Date | Feb 16, 2022 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 619 |
| CEO | Lee Leyi |
Contact Details
Address: 88 Tongda Road, Touqiao Town Yangzhou, 225000 China | |
| Phone | 86 051 4898 00199 |
| Website | meihuamed.com |
Stock Details
| Ticker Symbol | MHUA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001835615 |
| CUSIP Number | G5966G108 |
| ISIN Number | KYG5966G1082 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Lee Leyi | Chief Executive Officer and Director |
| Liao Shilong | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 21, 2025 | 6-K | Report of foreign issuer |
| Jul 24, 2025 | 424B3 | Prospectus |
| Jun 6, 2025 | 6-K | Report of foreign issuer |
| Apr 25, 2025 | 6-K | Report of foreign issuer |
| Apr 25, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Jan 3, 2025 | 6-K | Report of foreign issuer |
| Dec 11, 2024 | 6-K | Report of foreign issuer |
| Dec 5, 2024 | 6-K | Report of foreign issuer |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |